Pediatrix Medical Group, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.4% | -280.8% | – | -14.1% | +44.8% | -188.3% | – | +0.1% | -16.9% | -213.5% | – | – | |
| – | -1.6% | +13.7% | -14.7% | -28.9% | +9.9% | -22.4% | -0.4% | +4.5% | +1.4% | +10.5% | -7.1% | – | |
| – | -4.4% | +1.4% | -36.4% | +110.6% | -33.4% | +32.9% | +7.4% | +31.7% | +3.8% | -12.8% | +8.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -43.9% | -646.0% | – | -32.9% | +52.4% | -273.0% | – | -13.6% | -31.8% | -486.0% | – | – | |
| – | -1.2% | -41.1% | +30.6% | -9.7% | -45.3% | -3.5% | +36.1% | +18.2% | -1.0% | +18.2% | -77.9% | – | |
| – | -65.2% | +30.7% | -20.6% | -66.4% | -55.3% | +285.1% | -4.2% | – | -255.7% | +16.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -196.5% | -98.8% | +1,372.7% | +296.9% | +144.0% | -86.7% | +9,884.2% | +206.9% | -66.5% | +99.3% | – | |
| – | – | – | – | – | +5.0% | +26.7% | +3.3% | 0.0% | +2.9% | +26.0% | -2.4% | – | |
| – | -90.6% | – | -208.5% | -96.3% | +61.6% | +21.6% | -29.4% | +570.6% | +140.3% | -59.7% | +77.5% | – | |
| – | +239.7% | -225.3% | – | +640.3% | +49.4% | -203.8% | – | -8.3% | -69.5% | -581.7% | – | – | |
| – | -14.9% | -316.8% | – | -14.4% | +51.5% | -193.2% | – | -0.5% | -17.5% | -224.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.